OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Noninsulin‐based antihyperglycemic medications in patients with diabetes and COVID ‐19: A systematic review and meta‐analysis
Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 2, pp. 86-96
Open Access | Times Cited: 13
Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 2, pp. 86-96
Open Access | Times Cited: 13
Showing 13 citing articles:
Antidiabetic agent use and clinical outcomes in patients with diabetes hospitalized for COVID-19: a systematic review and meta-analysis
Jordan N. Keels, Isabella R. McDonald, Christopher S. Lee, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Jordan N. Keels, Isabella R. McDonald, Christopher S. Lee, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
SGLT2 Inhibitors in COVID-19: Umbrella Review, Meta-Analysis, and Bayesian Sensitivity Assessment
Vinay Suresh, Muhammad Aaqib Shamim, Victor Ghosh, et al.
Diseases (2025) Vol. 13, Iss. 3, pp. 67-67
Open Access
Vinay Suresh, Muhammad Aaqib Shamim, Victor Ghosh, et al.
Diseases (2025) Vol. 13, Iss. 3, pp. 67-67
Open Access
Insight on Infections in Diabetic Setting
Bianca Pari, Matteo Gallucci, Alberto Ghigo, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 971-971
Open Access | Times Cited: 9
Bianca Pari, Matteo Gallucci, Alberto Ghigo, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 971-971
Open Access | Times Cited: 9
An Updated Prioritization of Geroscience- Guided FDA-Approved Drugs Repurposed to Target Aging
Michael Leone, Nir Barzilai
Medical Research Archives (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 2
Michael Leone, Nir Barzilai
Medical Research Archives (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 2
Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy
Jelena Dimnjaković, Tamara Buble, Pero Ivanko, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Jelena Dimnjaković, Tamara Buble, Pero Ivanko, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Predicting Factors of Worse Prognosis in COVID-19: Results from a Cross-sectional Study on 52 Inpatients Admitted to the Internal Medicine Department
Giuseppe Lisco, Antonio Giovanni Solimando, Assunta Stragapede, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2024) Vol. 24, Iss. 10, pp. 1224-1236
Open Access | Times Cited: 1
Giuseppe Lisco, Antonio Giovanni Solimando, Assunta Stragapede, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2024) Vol. 24, Iss. 10, pp. 1224-1236
Open Access | Times Cited: 1
Association of anti-diabetic drugs and covid-19 outcomes in patients with diabetes mellitus type 2 and chronic kidney disease: Nationwide registry analysis
Jelena Dimnjaković, Tamara Buble, Pero Ivanko, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0301056-e0301056
Open Access | Times Cited: 1
Jelena Dimnjaković, Tamara Buble, Pero Ivanko, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0301056-e0301056
Open Access | Times Cited: 1
The impact of innovative glucose-lowering drugs on the course and outcome of COVID-19 in patients with type 2 diabetes mellitus
Т. Н. Маркова, M. Stas
Diabetes Mellitus (2024) Vol. 27, Iss. 2, pp. 174-184
Open Access | Times Cited: 1
Т. Н. Маркова, M. Stas
Diabetes Mellitus (2024) Vol. 27, Iss. 2, pp. 174-184
Open Access | Times Cited: 1
COVID-19 Outcomes and Diabetes Mellitus: A Comprehensive Multicenter Prospective Cohort Study
Karolina Akinosoglou, Georgios Schinas, Evanthia Bletsa, et al.
Microorganisms (2023) Vol. 11, Iss. 6, pp. 1416-1416
Open Access | Times Cited: 4
Karolina Akinosoglou, Georgios Schinas, Evanthia Bletsa, et al.
Microorganisms (2023) Vol. 11, Iss. 6, pp. 1416-1416
Open Access | Times Cited: 4
Why have SGLT2 Inhibitors Failed to Achieve the Desired Success in COVID-19?
Medine Cumhur Cüre, Erkan Cüre
Current Pharmaceutical Design (2024) Vol. 30, Iss. 15, pp. 1149-1156
Closed Access
Medine Cumhur Cüre, Erkan Cüre
Current Pharmaceutical Design (2024) Vol. 30, Iss. 15, pp. 1149-1156
Closed Access
SGLT2 Inhibitors in COVID-19: Umbrella Review, Meta-analysis, and Bayesian Sensitivity Assessment
Vinay Suresh, Muhammad Aaqib Shamim, Victor Ghosh, et al.
Research Square (Research Square) (2024)
Open Access
Vinay Suresh, Muhammad Aaqib Shamim, Victor Ghosh, et al.
Research Square (Research Square) (2024)
Open Access
Unveiling risk factors for post-COVID-19 syndrome development in people with type 2 diabetes
Anton Matviichuk, Viktoriia Yerokhovych, Сергій Земсков, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Anton Matviichuk, Viktoriia Yerokhovych, Сергій Земсков, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
